Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daphne M. Hullegie-Peelen"'
Autor:
Lukas K. van Vugt, Marieke van der Zwan, Marian C. Clahsen-van Groningen, Madelon van Agteren, Daphne M. Hullegie-Peelen, Brenda C. M. De Winter, Marlies E. J. Reinders, Pedro Miranda Afonso, Dennis A. Hesselink
Publikováno v:
Transplant International, Vol 36 (2023)
Alemtuzumab is used as lymphocyte-depleting therapy for severe or glucocorticoid-resistant kidney transplant rejection. However, the long-term efficacy and toxicity of alemtuzumab therapy are unclear. Therefore, all cases of alemtuzumab anti-rejectio
Externí odkaz:
https://doaj.org/article/cfd685a2a41d4895a6c64720351229a2
Autor:
Daphne M. Hullegie-Peelen, Hector Tejeda Mora, Dennis A. Hesselink, Eric M.J. Bindels, Thierry P.P. van den Bosch, Marian C. Clahsen-van Groningen, Marjolein Dieterich, Sebastiaan Heidt, Robert C. Minnee, Georges M.G.M. Verjans, Martin J. Hoogduijn, Carla C. Baan
Publikováno v:
JCI Insight, Vol 8, Iss 21 (2023)
Tissue-resident lymphocytes (TRLs) are critical for local protection against viral pathogens in peripheral tissue. However, it is unclear if TRLs perform a similar role in transplanted organs under chronic immunosuppressed conditions. In this study,
Externí odkaz:
https://doaj.org/article/fb29d72fe9e1487c9936e377474c2faa
Publikováno v:
Pharmacogenomics, 23(10), 567-570. Future Medicine Ltd.
Autor:
Daphne M. Hullegie‐Peelen, Marieke Zwan, Marian C. Clahsen‐van Groningen, Dana A.M. Mustafa, Sara J. Baart, Marlies E.J. Reinders, Carla C. Baan, Dennis A. Hesselink
Publikováno v:
Clinical Pharmacology and Therapeutics, 111(5), 1155-1164. Wiley-Blackwell
Alemtuzumab, a monoclonal antibody that depletes CD52-bearing immune cells, is an effective drug for the treatment of severe or glucocorticoid-resistant acute kidney transplant rejection (AR). Patient-specific predictions on treatment response are, h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dd7ebd8caa016b74e4f45f823727b79
https://pure.eur.nl/en/publications/ee9105cd-84bf-4040-8414-6145fae94da6
https://pure.eur.nl/en/publications/ee9105cd-84bf-4040-8414-6145fae94da6